U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from BioSample

ERX3168786: NextSeq 500 paired end sequencing; Transcriptomic response of Dickeya dadantii to DNA relaxation by novobiocin
1 ILLUMINA (NextSeq 500) run: 21.1M spots, 3.2G bases, 1.1Gb downloads

Design: Transcriptomic response of Dickeya dadantii to DNA relaxation by novobiocin
Submitted by: INSA Lyon (INSA LYON)
Study: Transcriptomic response of Dickeya dadantii to DNA relaxation by novobiocin
PRJEB31087 • ERP113600 • All experiments • All runs
show Abstracthide Abstract
We analyze the transcriptomic response of the phytopathogenic enterobacterium Dickeya dadantii to a DNA supercoiling relaxation shock using the gyrase inhibitor novobiocin. The shock was applied to Dickeya cells grown in minimal medium supplemented with sucrose, in exponential or transition to stationary phase, and in minimal medium with sucrose + PGA (a pectin derivative) in transition to stationary phase.
Sample: WT_stat_nov_1
SAMEA5315657 • ERS3122898 • All experiments • All runs
Organism: Dickeya dadantii
Library:
Name: WT_stat_nov_1_p
Instrument: NextSeq 500
Strategy: WGS
Source: TRANSCRIPTOMIC
Selection: RANDOM
Layout: PAIRED
Construction protocol: Cells were collected in exponential phase (OD=0.2 at 600nm) or transition to stationary phase (OD=1.5 at 600nm). Growth in minimal medium M63 supplemented with sucrose (0.2% wt/vol) Treated samples were subjected to 15 min novobiocin shock (100 ug/ml) Total RNA from each D. dadantii sample was isolated using the frozen acid phenol method (Maes et Messens 1992), and submitted to Vertis Biotechnologie AG for ribosomal depletion (Illumina RiboZero kit) and RNA fragmentation. Strand-specific cDNA libraries were constructed by Vertis Biotechnologie AG.
Spot descriptor:
1  forward76  reverse

Experiment attributes: (show all 4 attributes...) (hide...)
Experimental Factor: growth condition: M63, sucrose
Experimental Factor: growth phase: transition to stationary
Experimental Factor: compound: novobiocin
Experimental Factor: dose: 100
Runs: 1 run, 21.1M spots, 3.2G bases, 1.1Gb
Run# of Spots# of BasesSizePublished
ERR313981321,137,7073.2G1.1Gb2019-04-17

ID:
7680716

Supplemental Content

Related information

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...